Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

We all deserve generic drugs that we can trust. Our latest webinar will connect consumers and healthcare professionals to whistleblowers and industry insiders who are working on real solutions to improve drug quality and safety for everyone.

Peter Baker

President

Live Oak Quality Assurance and Former FDA Inspector

Rosemary Gibson

Author

China Rx: Exposing the Risks of America's Dependence on China for Medicine

John Gray, PhD

Dean’s Distinguished Professor,

Department of Operations and Business Analytics, Ohio State University

Suzanne Robotti

Founder and President,

MedShadow Foundation

Say No to Putting Profits Over Patient Safety

Gain critical insight into efforts to change the supply chain for generics so everyone can have access to safe and effective drugs.

Improve Manufacturing Oversight

Learn about efforts to reform lax oversight of manufacturing plants that put people in harm’s way.

Support Innovative Solutions

See how new quality scores aim to make the efficacy and purity of drugs more transparent, and what steps need to be taken to make this a reality.

Drive Policy Change

Discover ongoing policy initiatives designed to ensure pharmacy middlemen select only high-quality generics.

Meet Our Speakers

Hear from whistleblowers and industry insiders working at the forefront of the battle against low-quality generic drugs.

Peter Baker

President,
Live Oak Quality Assurance and Former FDA Inspector

Baker spent 11 years as a U.S. FDA Drug Investigator; he was named investigator of the year in 2013 for his inspections of nearly 50 overseas generic plants that resulted in landmark findings and the restriction of overseas products. Today, as president of Live Oak Quality Assurance, Baker works to improve the quality of medicines by providing training and consulting services to organizations to improve their data processes. The story of his FDA work was featured prominently in Katherine Eban’s award-winning book, Bottle of Lies. He has also testified before Congress on the topic of FDA inspections.

Rosemary Gibson

Author,
China Rx: Exposing the Risks of America's Dependence on China for Medicine

Gibson is an influential author and lecturer who has received the American Medical Writers Association’s highest honor for her contributions to reporting on critical health issues, as well as the Lifetime Achievement Award from the American Academy of Hospice and Palliative Medicine. Her recent work documenting harm caused by generics builds public awareness, which she hopes to harness to drive concrete change.

John Gray, PhD

Dean’s Distinguished Professor,
Department of Operations and Business Analytics, Ohio State University

Gray’s award-winning research explores how generic drugs are made, revealing the production and supply chain decisions that make a meaningful difference in quality, along with possible improvements to the industry. He has published multiple papers on the subject and currently has a Department of Defense grant to create a quality score system that would give consumers more transparency as they make purchase decisions.

Suzanne Robotti

Founder and President,
MedShadow Foundation

Robotti founded MedShadow Foundation in 2013. As a patient safety advocate, Robotti served on the FDA Advisory Committee on Drug Safety and Risk Management as the only consumer representative alongside doctors and pharmacists from 2017 to 2024. She writes and speaks extensively on known and lesser-known drug side effects, interactions, and supply chain issues related to OTC and prescription drugs.

Low-Quality Generic Drugs are a Threat to Americans’ Health

Help us fight for a safer future for everyone.

Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.